RPAM
PFE icon

Rhenman & Partners Asset Management’s Pfizer PFE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-580,000
Closed -$16.7M 93
2023
Q4
$16.7M Buy
+580,000
New +$16.7M 1.67% 21
2023
Q2
Sell
-190,000
Closed -$7.67M 88
2023
Q1
$7.67M Sell
190,000
-160,000
-46% -$6.46M 0.84% 39
2022
Q4
$17.9M Hold
350,000
1.87% 20
2022
Q3
$16.3M Sell
350,000
-190,000
-35% -$8.84M 1.71% 22
2022
Q2
$28.3M Buy
540,000
+17,500
+3% +$918K 3.22% 5
2022
Q1
$27.1M Sell
522,500
-477,500
-48% -$24.7M 2.67% 7
2021
Q4
$58.4M Hold
1,000,000
3.88% 2
2021
Q3
$43M Buy
1,000,000
+500,000
+100% +$21.5M 3.02% 5
2021
Q2
$19.6M Buy
+500,000
New +$19.6M 1.33% 32
2020
Q3
Sell
-4,508
Closed -$147K 91
2020
Q2
$147K Buy
+4,508
New +$147K 0.02% 90
2019
Q2
Sell
-5,009
Closed -$213K 93
2019
Q1
$213K Hold
5,009
0.02% 91
2018
Q4
$219K Sell
5,009
-3,745
-43% -$164K 0.03% 88
2018
Q3
$386K Hold
8,754
0.04% 78
2018
Q2
$318K Hold
8,754
0.03% 86
2018
Q1
$311K Sell
8,754
-1,668
-16% -$59.3K 0.04% 90
2017
Q4
$377K Hold
10,422
0.05% 90
2017
Q3
$372K Sell
10,422
-420,000
-98% -$15M 0.05% 88
2017
Q2
$14.5M Buy
430,422
+95,000
+28% +$3.19M 2.08% 14
2017
Q1
$11.5M Buy
335,422
+2,122
+0.6% +$72.6K 1.82% 18
2016
Q4
$10.8M Buy
+333,300
New +$10.8M 2.08% 15
2016
Q3
Sell
-375,000
Closed -$13.2M 115
2016
Q2
$13.2M Sell
375,000
-100,000
-21% -$3.52M 2.34% 8
2016
Q1
$14.1M Buy
475,000
+37,000
+8% +$1.1M 2.79% 4
2015
Q4
$14.1M Buy
438,000
+17,000
+4% +$549K 2.14% 9
2015
Q3
$13.2M Buy
+421,000
New +$13.2M 2.11% 14
2014
Q2
Sell
-352,989
Closed -$11.3M 103
2014
Q1
$11.3M Buy
+352,989
New +$11.3M 3.4% 5